Qiuzhen Liu
Overview
Explore the profile of Qiuzhen Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li K, Yang M, Dai Y, Huang J, Zhu P, Liu Q
Toxicon
. 2024 Jun;
247:107796.
PMID: 38901122
No abstract available.
2.
Wei Z, Ye S, Feng H, Zeng C, Dong X, Zeng X, et al.
Cancer Sci
. 2022 Jun;
113(9):3032-3043.
PMID: 35730256
Metabolic reprogramming is a sign of malignant tumors, and targeting the metabolism of tumor cells has become a promising therapeutic approach. Here, we report that Silybin (a nontoxic flavonoid commonly...
3.
Chen X, Zou Z, Wang Q, Gao W, Zeng S, Ye S, et al.
J Transl Med
. 2022 May;
20(1):205.
PMID: 35538490
Background: NOS1 expression predicts poor prognosis in patients with melanoma. However, the molecular function of NOS1 in the type I IFN response and immune escape of melanoma is still unknown....
4.
Yang B, Li L, Tong G, Zeng Z, Tan J, Su Z, et al.
J Exp Clin Cancer Res
. 2021 Jul;
40(1):235.
PMID: 34271943
Background: Circular RNAs (circRNAs) are involved in diverse processes that drive cancer development. However, the expression landscape and mechanistic function of circRNAs in osteosarcoma (OS) remain to be studied. Methods:...
5.
Gao W, Huang M, Chen X, Chen J, Zou Z, Li L, et al.
Cell Death Dis
. 2021 Apr;
12(4):408.
PMID: 33859186
One of the malignant transformation hallmarks is metabolism reprogramming, which plays a critical role in the biosynthetic needs of unchecked proliferation, abrogating cell death programs, and immunologic escape. However, the...
6.
Ye S, Xu P, Huang M, Chen X, Zeng S, Wang Q, et al.
Cell Death Dis
. 2020 May;
11(5):312.
PMID: 32366855
Tempol (4-hydroxy-2,2,6,6-Tetramethylpiperidine-1-oxyl, TPL), a nitroxide compound, inhibits proliferation and increases the vulnerability of cancer cells to apoptosis induced by cytotoxic agents. However, the molecular mechanism of TPL inhibiting cancer cell...
7.
Zou Z, Li X, Sun Y, Li L, Zhang Q, Zhu L, et al.
Oncol Lett
. 2020 Mar;
19(4):2989-2995.
PMID: 32218855
Nitric oxide (NO), an important chemical messenger, serves a dual role in tumor progression. Nitric oxide synthase isoform 1 (NOS1) was observed to be increasingly expressed in various types of...
8.
Li K, Huang M, Xu P, Wang M, Ye S, Wang Q, et al.
Ecotoxicol Environ Saf
. 2020 Jan;
190:110096.
PMID: 31901813
Microcystins-LR (MC-LR), a cyanobacterial toxins, initiate apoptosis in normal and tumor cells. Nitric oxide produced by iNOS is necessary for MC-LR-induced apoptosis. However, the underlying mechanism of NO mediated MC-LR...
9.
Xu P, Ye S, Li K, Huang M, Wang Q, Zeng S, et al.
J Exp Clin Cancer Res
. 2019 Dec;
38(1):483.
PMID: 31805977
Background: The dysfunction of type I interferon (IFN) signaling is an important mechanism of immune escape and metastasis in tumors. Increased NOS1 expression has been detected in melanoma, which correlated...
10.
Hu L, Zeng Z, Xia Q, Liu Z, Feng X, Chen J, et al.
Life Sci
. 2019 Oct;
239:116966.
PMID: 31626790
Aims: Enhanced aerobic glycolysis is an essential hallmark of malignant cancer. Blocking the glycolytic pathway has been suggested as a therapeutic strategy to impair the proliferation of tumor cells. Metformin,...